Data gathered as part of the ongoing ProtecT study in the United Kingdom provides no evidence that regular use of non-steroidal anti-inflammatory drugs l(NSAIDs) lowers risk for prostate cancer. … READ MORE …
Filed under: Prevention | Tagged: acetaminophen, aspirin, inflammation, NSAID | Leave a comment »
Data presented last Monday at the annual meeting of the American Society for Radiation Oncology (ASTRO) suggest a possible role of anticoagulant therapy (using drugs like aspirin, warfarin, or clopidogrel/Plavix) in combination with radiation for the treatment of localized prostate cancer. … READ MORE …
Filed under: Management, Treatment | Tagged: anticoagulant, aspirin, clopidogrel, radiation, warfarin | Leave a comment »
Over the years there have been several studies suggesting that regular use of non-steroidal anti-inflammatory agents (NSAIDs) — the most common being aspirin — can decrease prostate inflammation and prostate cancer risk. Since aspirin and other NSAIDs are commonly used to prevent cardiovascular disease, it will be apparent that there is going to be relatively high use of these agents in the men who are also at some degree of risk for prostate cancer. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: aspirin, NSAID, Prevention, PSA level, volume | Leave a comment »
On October 31st we reported that statins lower PSA levels. Now comes evidence that aspirin and other NSAIDs also lower PSA levels, in both patients with prostate cancer and in men with no prostate cancer diagnosis. … READ MORE …
Filed under: Diagnosis, Prevention, Treatment | Tagged: aspirin, NSAID, Prevention | Leave a comment »
THE "NEW" PROSTATE CANCER INFOLINK 